Kalfin R E, Engelman R M, Rousou J A, Flack J E, Deaton D W, Kreutzer D L, Das D K
Department of Surgery University of Connecticut Health Center, Farmington.
Circulation. 1993 Nov;88(5 Pt 2):II401-6.
Patients undergoing cardiopulmonary bypass (CPB) are known to suffer from a postsurgical systemic inflammatory response, the nature of which remains to be fully elucidated. Interleukin-8 (IL-8) is a newly described, powerful leukocyte chemotactic factor known to be generated after stimulation of interleukin-1 (IL-1). As we have previously documented the generation of IL-1 beta after CPB, it followed that IL-8 generation should be measured in a comparable group of patients.
Twenty-two adult patients aged 41 to 81 years undergoing coronary revascularization were studied for measurements of C3a, C5a, IL-1, IL-8, and OH(.). Blood was collected before surgery, after CPB, and at 24, 48, and 72 hours. A significant increase in IL-1 beta and IL-8 was detected in circulating leukocytes with peak levels at 24 hours after bypass. No IL-1 beta or IL-8 antigen was detected at any time in patient plasma. Comparable to interleukin generation, human complement-derived C5a also peaked after 24 hours, whereas C3a was increased dramatically immediately after CPB, followed by a decline at 24 hours and a progressive increase over the next 48 hours.
The results demonstrated for the first time the presence of cell-associated IL-8 in CPB patients. This suggests that this powerful polymorphonuclear and T-lymphocyte chemotactic factor may be an important element in leukocyte activation and recruitment after CPB.
已知接受体外循环(CPB)的患者会遭受术后全身性炎症反应,但其本质仍有待充分阐明。白细胞介素-8(IL-8)是一种新描述的强效白细胞趋化因子,已知在白细胞介素-1(IL-1)刺激后产生。由于我们之前已记录了CPB后IL-1β的产生,因此应该在一组类似的患者中测量IL-8的产生。
对22例年龄在41至81岁接受冠状动脉血运重建的成年患者进行研究,以测量C3a、C5a、IL-1、IL-8和OH(.)。在手术前、CPB后以及24、48和72小时采集血液。在循环白细胞中检测到IL-1β和IL-8显著增加,在体外循环后24小时达到峰值水平。在患者血浆中任何时候都未检测到IL-1β或IL-8抗原。与白细胞介素产生情况类似,人补体衍生的C5a在24小时后也达到峰值,而C3a在CPB后立即显著增加,随后在24小时下降,并在接下来的48小时逐渐增加。
结果首次证明了CPB患者中存在细胞相关的IL-8。这表明这种强效的多形核白细胞和T淋巴细胞趋化因子可能是CPB后白细胞激活和募集的重要因素。